Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
Why the study?
Does prior treatment with mediastinal radiotherapy and anthracyclines lead to progressive valvular dysfunction and left ventricular remodeling in Hodgkin's lymphoma survivors?
Population
51 Hodgkin's lymphoma survivors evaluated median 22 years after treatment with mediastinal radiotherapy…
Design
Cohort
Follow-up
median 22 years (range 11-27 years) after treatment
Authors
Discussion
Loading...
Member takes
Implication
May support extended surveillance in Hodgkin survivors; extends observational data but leaves causal effects open for prospective trials.
Structured PICO
Does prior treatment with mediastinal radiotherapy and anthracyclines lead to progressive valvular dysfunction and left ventricular remodeling in Hodgkin's lymphoma survivors?
P
Population
51 Hodgkin's lymphoma survivors evaluated median 22 years (range 11-27 years) after treatment with mediastinal radiotherapy, selected based on the presence or absence of moderate valvular regurgitation in a prior 1993 echocardiogram. 28 (55%) had also received anthracyclines.
I
Intervention
Mediastinal radiotherapy with or without anthracyclines
O
Outcome
Time-dependent development and evolution of valvular and myocardial function assessed by echocardiographysurrogate
Hodgkin's lymphoma survivors treated with mediastinal radiotherapy and anthracyclines demonstrate progressive valvular dysfunction and left ventricular remodeling 20-30 years post-treatment, warranting lifelong cardiological follow-up.
Cite This Study
Wethal et al. (2009) studied this question.